TesoRx Pharma is a pharmaceutical company developing oncology and hormonal therapies. It uses LiPax, a proprietary drug delivery platform to provide urology and oncology products. The company supplies medications for bladder and ovarian cancer, carcinoma, and malignant pleural mesothelioma. In addition, TesoRx provides an oral formulation designed to help restore normal testosterone levels in males with hypogonadism.
|Employees (est.) (Mar 2020)||8|
TesoRx total Funding
TesoRx latest funding size
Time since last funding
|6 years ago|
When was TesoRx founded?
TesoRx was founded in 2010.
Who are TesoRx key executives?
TesoRx's key executives are Ramachandran R. Thirucote and Betageri.
How many employees does TesoRx have?
TesoRx has 8 employees.
Who are TesoRx competitors?
Competitors of TesoRx include Merrimack Pharmaceuticals, Calithera Biosciences and TESARO.
Receive alerts for 300+ data fields across thousands of companies